Tatva Chintan Pharma Chem Future Growth
Future criteria checks 5/6
Tatva Chintan Pharma Chem is forecast to grow earnings and revenue by 45.5% and 23% per annum respectively. EPS is expected to grow by 45.3% per annum. Return on equity is forecast to be 10.9% in 3 years.
Key information
45.5%
Earnings growth rate
45.3%
EPS growth rate
Chemicals earnings growth | 20.8% |
Revenue growth rate | 23.0% |
Future return on equity | 10.9% |
Analyst coverage | Low |
Last updated | 30 Jul 2024 |
Recent future growth updates
Recent updates
Tatva Chintan Pharma Chem Limited's (NSE:TATVA) Price In Tune With Revenues
Sep 26Tatva Chintan Pharma Chem (NSE:TATVA) Has Affirmed Its Dividend Of ₹2.00
Aug 29Earnings Report: Tatva Chintan Pharma Chem Limited Missed Revenue Estimates By 33%
Jul 27Weak Statutory Earnings May Not Tell The Whole Story For Tatva Chintan Pharma Chem (NSE:TATVA)
May 11Tatva Chintan Pharma Chem Limited's (NSE:TATVA) Share Price Matching Investor Opinion
Apr 04These Analysts Just Made A Notable Downgrade To Their Tatva Chintan Pharma Chem Limited (NSE:TATVA) EPS Forecasts
Jan 26Tatva Chintan Pharma Chem Limited (NSE:TATVA) Analysts Are Reducing Their Forecasts For This Year
May 10Tatva Chintan Pharma Chem Limited Just Missed Revenue By 15%: Here's What Analysts Think Will Happen Next
Jul 28Getting In Cheap On Tatva Chintan Pharma Chem Limited (NSE:TATVA) Is Unlikely
Jun 17Investors Shouldn't Be Too Comfortable With Tatva Chintan Pharma Chem's (NSE:TATVA) Robust Earnings
May 03Are Investors Undervaluing Tatva Chintan Pharma Chem Limited (NSE:TATVA) By 45%?
Dec 06Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
3/31/2027 | 6,652 | 909 | 234 | N/A | 1 |
3/31/2026 | 6,759 | 913 | 103 | N/A | 3 |
3/31/2025 | 5,070 | 507 | -278 | N/A | 3 |
6/30/2024 | 3,846 | 261 | N/A | N/A | N/A |
3/31/2024 | 3,935 | 304 | -305 | 980 | N/A |
12/31/2023 | 4,198 | 377 | N/A | N/A | N/A |
9/30/2023 | 4,562 | 459 | -590 | 1,145 | N/A |
6/30/2023 | 4,496 | 452 | N/A | N/A | N/A |
3/31/2023 | 4,236 | 455 | -1,753 | 278 | N/A |
12/31/2022 | 3,976 | 460 | N/A | N/A | N/A |
9/30/2022 | 3,817 | 572 | -1,480 | -99 | N/A |
6/30/2022 | 4,152 | 825 | N/A | N/A | N/A |
3/31/2022 | 4,336 | 959 | -689 | 202 | N/A |
12/31/2021 | 4,438 | 995 | N/A | N/A | N/A |
9/30/2021 | 4,192 | 976 | N/A | N/A | N/A |
6/30/2021 | 3,557 | 687 | N/A | N/A | N/A |
3/31/2021 | 3,004 | 523 | -13 | 197 | N/A |
3/31/2020 | 2,632 | 378 | -229 | 253 | N/A |
3/31/2019 | 2,063 | 205 | -24 | 74 | N/A |
3/31/2018 | 1,358 | 123 | N/A | 126 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: TATVA's forecast earnings growth (45.5% per year) is above the savings rate (6.7%).
Earnings vs Market: TATVA's earnings (45.5% per year) are forecast to grow faster than the Indian market (17.3% per year).
High Growth Earnings: TATVA's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: TATVA's revenue (23% per year) is forecast to grow faster than the Indian market (10.1% per year).
High Growth Revenue: TATVA's revenue (23% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: TATVA's Return on Equity is forecast to be low in 3 years time (10.9%).